Fulton Bank, N.A. Abb Vie Inc. Transaction History

Fulton Bank, N.A.

$1.19 Billion
Q3 2024

A detailed history of Fulton Bank, N.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Fulton Bank, N.A. holds 47,711 shares of ABBV stock, worth $8.38 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

47,711

Previous 47,987 0.58%

Holding current value

$8.38 Million

Previous $8.23 Million 14.47%

% of portfolio

0.79%

Previous 0.74%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$163.84 - $199.33 $45,219 - $55,015	-276 Reduced 0.58%	47,711 $9.42 Million
Q2 2024 Jul 09, 2024	BUY	$154.79 - $180.76 $721,476 - $842,522	4,661 Added 10.76%	47,987 $8.23 Million
Q1 2024 Apr 10, 2024	SELL	$159.82 - $182.1 $252,515 - $287,718	-1,580 Reduced 3.52%	43,326 $7.89 Million
Q4 2023 Jan 04, 2024	BUY	$137.6 - $154.97 $298,592 - $336,284	2,170 Added 5.08%	44,906 $6.96 Million
Q3 2023 Oct 04, 2023	BUY	$133.59 - $154.65 $51,565 - $59,694	386 Added 0.91%	42,736 $6.37 Million
Q2 2023 Jul 06, 2023	SELL	$132.51 - $164.9 $161,132 - $200,518	-1,216 Reduced 2.79%	42,350 $5.71 Million
Q1 2023 Apr 06, 2023	SELL	$144.61 - $166.54 $203,177 - $233,988	-1,405 Reduced 3.12%	43,566 $6.94 Million
Q4 2022 Jan 05, 2023	SELL	$138.31 - $165.87 $253,522 - $304,039	-1,833 Reduced 3.92%	44,971 $7.27 Million
Q3 2022 Oct 04, 2022	SELL	$134.21 - $153.93 $45,765 - $52,490	-341 Reduced 0.72%	46,804 $6.28 Million
Q2 2022 Jul 07, 2022	SELL	$137.62 - $174.96 $1.54 Million - $1.96 Million	-11,189 Reduced 19.18%	47,145 $7.22 Million
Q1 2022 Apr 05, 2022	SELL	$131.98 - $163.75 $1.23 Million - $1.53 Million	-9,355 Reduced 13.82%	58,334 $9.46 Million
Q4 2021 Jan 05, 2022	SELL	$107.43 - $135.93 $65,424 - $82,781	-609 Reduced 0.89%	67,689 $9.17 Million
Q3 2021 Oct 05, 2021	SELL	$106.4 - $120.78 $239,187 - $271,513	-2,248 Reduced 3.19%	68,298 $7.37 Million
Q2 2021 Jul 06, 2021	SELL	$105.21 - $117.21 $117,098 - $130,454	-1,113 Reduced 1.55%	70,546 $7.95 Million
Q1 2021 Apr 05, 2021	SELL	$102.3 - $112.62 $20,971 - $23,087	-205 Reduced 0.29%	71,659 $7.76 Million
Q4 2020 Jan 07, 2021	BUY	$80.49 - $108.67 $12,314 - $16,626	153 Added 0.21%	71,864 $7.7 Million
Q3 2020 Oct 06, 2020	SELL	$85.91 - $100.83 $432,642 - $507,779	-5,036 Reduced 6.56%	71,711 $6.28 Million
Q2 2020 Jul 06, 2020	SELL	$73.37 - $98.18 $126,269 - $168,967	-1,721 Reduced 2.19%	76,747 $7.54 Million
Q1 2020 Apr 03, 2020	BUY	$64.5 - $97.79 $60,436 - $91,629	937 Added 1.21%	78,468 $5.98 Million
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $137,984 - $172,648	1,913 Added 2.53%	77,531 $6.86 Million
Q3 2019 Oct 03, 2019	BUY	$62.98 - $75.72 $155,056 - $186,422	2,462 Added 3.37%	75,618 $5.73 Million
Q2 2019 Jul 03, 2019	SELL	$65.7 - $83.98 $3,613 - $4,618	-55 Reduced 0.08%	73,156 $5.32 Million
Q1 2019 Apr 03, 2019	BUY	$77.14 - $90.79 $505,806 - $595,310	6,557 Added 9.84%	73,211 $5.9 Million
Q4 2018 Jan 03, 2019	BUY	$77.85 - $96.01 $944,709 - $1.17 Million	12,135 Added 22.26%	66,654 $6.14 Million
Q3 2018 Oct 03, 2018	BUY	$88.91 - $98.84 $1.32 Million - $1.47 Million	14,869 Added 37.5%	54,519 $5.16 Million
Q2 2018 Jul 10, 2018	SELL	$89.78 - $106.23 $683,674 - $808,941	-7,615 Reduced 16.11%	39,650 $3.67 Million
Q1 2018 May 02, 2018	SELL	$92.01 - $123.21 $996,284 - $1.33 Million	-10,828 Reduced 18.64%	47,265 $4.47 Million
Q4 2017 Jan 04, 2018	SELL	$89.56 - $98.21 $1.46 Million - $1.6 Million	-16,283 Reduced 21.89%	58,093 $5.62 Million
Q3 2017 Oct 04, 2017	BUY	$69.85 - $89.22 $5.2 Million - $6.64 Million	74,376	74,376 $6.61 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.

Account